Screener/Healthcare/Biotechnology

OTLK

Outlook Therapeutics, Inc.NASDAQ
$0.19-0.13 (-39.40%)
$0.16
$3.39
$0.16
$0.22
EPS (TTM)$-2.62
P/E Ratio
Dividend Yield
Market Cap$18.4M
Volume23.76M
Prev Close$0.32
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26-$1.2M-$23.1M$-0.38100.0%1863.3%
Q4 '25-$92K-$13.3M$-0.191098.5%14482.2%
Q3 '25$1.5M-$20.2M$-0.5570.8%-1338.8%
Q2 '25-$19K-$46.4M$-1.50250552.4%
Q1 '25$49K$17.4M$0.4535550.9%
Q4 '24$170K$5.7M$0.7650.0%3345.4%
Q3 '24$0$44.4M$-0.89
Q2 '24-$3.1M-$114.3M$-8.013705.8%
Get Your Daily Market Recap